Avadel Pharmaceuticals (AVDL) Net Cash Flow: 2009-2024
Historic Net Cash Flow for Avadel Pharmaceuticals (AVDL) over the last 16 years, with Dec 2024 value amounting to $20.8 million.
- Avadel Pharmaceuticals' Net Cash Flow rose 296.65% to $14.1 million in Q4 2022 from the same period last year, while for Dec 2022 it was $23.9 million, marking a year-over-year increase of 218.98%. This contributed to the annual value of $20.8 million for FY2024, which is 148.17% up from last year.
- Avadel Pharmaceuticals' Net Cash Flow amounted to $20.8 million in FY2024, which was up 148.17% from -$43.3 million recorded in FY2023.
- In the past 5 years, Avadel Pharmaceuticals' Net Cash Flow registered a high of $61.2 million during FY2020, and its lowest value of -$43.3 million during FY2023.
- Over the past 3 years, Avadel Pharmaceuticals' median Net Cash Flow value was $20.8 million (recorded in 2024), while the average stood at $503,667.
- Per our database at Business Quant, Avadel Pharmaceuticals' Net Cash Flow spiked by 16,403.50% in 2020 and then tumbled by 280.76% in 2023.
- Avadel Pharmaceuticals' Net Cash Flow (Yearly) stood at $61.2 million in 2020, then slumped by 132.86% to -$20.1 million in 2021, then soared by 218.98% to $23.9 million in 2022, then crashed by 280.76% to -$43.3 million in 2023, then spiked by 148.17% to $20.8 million in 2024.